Name | EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO |
|---|
INN | 7838485074 |
|---|
KPP | 780201001 |
|---|
OGRN | 1137847000752 |
|---|
OKPO | 11128677 |
|---|
Address | 194156, G.Sankt-Peterburg, pr-kt. Engel'sa, d. 27, pomesch. 41N |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other |
Registration date | 09.01.2013 |
|---|
|
EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO (Saint Petersburg; INN 7838485074) was registered on 9 Jan 2013. The company's authorized capital as of July 1, 2012 was 10000 rub. Principal activities of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO: research and experimental development on natural sciences and engineering other (72.19). |
Economic indicators2023
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO dropped in 2023 by 47.54% to 4.30 million RUB from 8.20 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 2.23% to 91.08 million RUB from 89.10 million RUB over 2022. 2022
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO grew over 2022 by 8.33% to 8.78 million RUB from 8.11 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 10.10% to 89.10 million RUB from 99.11 million RUB in 2021. 2021
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO dropped in 2021 2.47 times to 8.09 million RUB from 19.97 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 19.00% to 99.11 million RUB from 122.35 million RUB in 2020. 2020
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO grew over 2020 by 39.53% to 19.97 million RUB from 14.31 million RUB over 2019, the company informed. Revenue increased in the accounting period by 46.96% to 122.35 million RUB from 83.25 million RUB over 2019. 2018
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO grew over 2018 134.27 times to 4.97 million RUB from 37.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period 6.54 times to 27.91 million RUB from 4.27 million RUB over 2017; cost of goods sold grew 5.55 times to 20.79 million RUB from 3.75 million RUB; sales profit went up 13.54 times to 7.12 million RUB from 526.00 thousand RUB. 2017
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO grew over 2017 2.31 times to 37.00 thousand RUB from 16.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 37.71% to 4.48 million RUB from 3.26 million RUB over 2016; cost of goods sold grew by 23.37% to 4.04 million RUB from 3.27 million RUB; sales profit made up 445.00 thousand RUB compared to sales loss of 18.00 thousand RUB. 2016
Net profit (RAS) of EKS SEVEN KLINIKALS END FARMAS'YUTIKALS RESECH, OOO dropped in 2016 2.47 times to 15.00 thousand RUB from 37.00 thousand RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 47.33% to 3.26 million RUB from 2.21 million RUB over 2015; cost of goods sold grew 1.54 times to 3.27 million RUB from 2.12 million RUB; sales loss made up 18.00 thousand RUB compared to sales profit of 89.00 thousand RUB. 2014
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|